Clinical trial
Dexmedetomidine Versus Propofol for Continuous Sedation in the Intensive Care…
NCT00479661 · Orion Corporation, Orion Pharma, Industry · Completed
Key facts
| NCT number | NCT00479661 |
|---|---|
| Title | Dexmedetomidine Versus Propofol for Continuous Sedation in the Intensive Care Unit (ICU) |
| Official title | A Prospective, Multi-centre, Randomised, Double-blind Comparison of Intravenous Dexmedetomidine With Propofol for Continuous Sedation of Ventilated Patients in Intensive Care Unit |
| Acronym | Prodex |
| Lead sponsor | Orion Corporation, Orion Pharma, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Continuous Sedation in Initially Sedated Adults in ICU |
| Intervention type | Drug |
| Interventions | Dexmedetomidine, Propofol |
| Enrollment | 500 |
| Start date | May 1, 2007 |
| Primary completion | Mar 1, 2010 |
| Completion | Mar 1, 2010 |
| First posted | May 28, 2007 |
| Last update posted | Aug 13, 2010 |
| Countries | Belgium, Finland, Germany, Netherlands, Russia, Switzerland, United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: